4.7 Article

α2δ-1 Upregulation in Primary Sensory Neurons Promotes NMDA Receptor-Mediated Glutamatergic Input in Resiniferatoxin-Induced Neuropathy

Journal

JOURNAL OF NEUROSCIENCE
Volume 41, Issue 27, Pages 5963-5978

Publisher

SOC NEUROSCIENCE
DOI: 10.1523/JNEUROSCI.0303-21.2021

Keywords

dorsal root ganglion; gabapentinoid; pregabalin; neuropathic pain; NMDA receptor; spinal cord; synaptic plasticity

Categories

Funding

  1. National Institutes of Health [NS101880, GM120844]
  2. N. G. and Helen T. Hawkins Endowment

Ask authors/readers for more resources

Systemic treatment with resiniferatoxin (RTX) induces small-fiber sensory neuropathy by damaging TRPV1-expressing primary sensory neurons and leads to distinct thermal sensory impairments and tactile allodynia. The synaptic plasticity associated with RTX-induced tactile allodynia involves alpha 2 delta-1 upregulation in the dorsal root ganglion (DRG) and increased physical interaction between alpha 2 delta-1 and GluN1 in spinal cord synaptosomes, leading to potentiation of nociceptive input and tactile allodynia.
Systemic treatment with resiniferatoxin (RTX) induces small-fiber sensory neuropathy by damaging TRPV1-expressing primary sensory neurons and causes distinct thermal sensory impairment and tactile allodynia, which resemble the unique clinical features of postherpetic neuralgia. However, the synaptic plasticity associated with RTX-induced tactile allodynia remains unknown. In this study, we found that RTX-induced neuropathy is associated with alpha 2 delta-1 upregulation in the dorsal root ganglion (DRG) and increased physical interaction between alpha 2 delta-1 and GluN1 in the spinal cord synaptosomes. RNAscope in situ hybridization showed that RTX treatment significantly increased alpha 2 delta-1 expression in DRG neurons labeled with calcitonin gene-related peptide, isolectin B4, NF200, and tyrosine hydroxylase. Electrophysiological recordings revealed that RTX treatment augmented the frequency of miniature excitatory postsynaptic currents (mEPSCs) and the amplitude of evoked EPSCs in spinal dorsal horn neurons, and these effects were reversed by blocking NMDA receptors with AP-5. Inhibiting alpha 2 delta-1 with gabapentin, genetically ablating alpha 2 delta-1, or targeting alpha 2 delta-1-bound NMDA receptors with alpha 2 delta-1 Tat peptide largely normalized the baseline frequency of mEPSCs and the amplitude of evoked EPSCs potentiated by RTX treatment. Furthermore, systemic treatment with memantine or gabapentin and intrathecal injection of AP-5 or Tat-fused alpha 2 delta-1 C terminus peptide reversed allodynia in RTX-treated rats and mice. In addition, RTX-induced tactile allodynia was attenuated in alpha 2 delta-1 knock-out mice and in mice in which GluN1 was conditionally knocked out in DRG neurons. Collectively, our findings indicate that alpha 2 delta-1-bound NMDA receptors at presynaptic terminals of sprouting myelinated afferent nerves contribute to RTX-induced potentiation of nociceptive input to the spinal cord and tactile allodynia.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available